Outcomes of Emotion Regulation Therapy in Young Autistic Adults
NCT ID: NCT05341505
Last Updated: 2022-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
5 participants
INTERVENTIONAL
2022-07-15
2023-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Intervention Program to Improve Emotion Regulation Among Parents of Children with ASD
NCT06598605
Parents Workgroup About Emotion Regulation
NCT02400177
Transcranial Magnetic Stimulation on Neural and Behavioral Facets of Social Cognition in Autism Spectrum Disorder
NCT04242355
Emotion Regulation in Preschoolers With Autism and Their Parents
NCT01643720
Development of Self-regulation by Dialectial Behavioural Therapy in Adults With Autism
NCT05502484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ER intervention
Cognitive-behavioral emotion regulation intervention administered twice weekly for 8 weeks.
Emotion Regulation Intervention
We will administer a cognitive-behavioral treatment targeting emotion dysregulation, including mindfulness skills and other cognitive and behavioral emotion regulation skills.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Emotion Regulation Intervention
We will administer a cognitive-behavioral treatment targeting emotion dysregulation, including mindfulness skills and other cognitive and behavioral emotion regulation skills.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ages 18-40
* Estimated full-scale IQ ≥ 80
* T score \> 60 on either the externalizing or internalizing symptoms scores of either the Adult Behavior Checklist (ABC-L) or the Adult Self Report (ASR)
* Participation in previous study at the Olin Center ("Social Emotional Study"; E-HHC- 2018-0241)
Exclusion Criteria
* History of a significant head injury (severe concussion, hospitalization)
* History of neurosurgery
* History of epilepsy, stroke, MS, a neurodegenerative disorder, or any other neurological disorder
* A current major medical condition (e.g. cancer, heart failure)
* Current substance use (determined by urine screen done to all participants before each MRI scan)
* In-body metal implants (e.g. surgical clips, certain pacemakers) or history of exposure to metal shards or other MRI contraindications
* Pregnancy
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Michal Assaf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michal Assaf
Director, Autism & Functional Mappin lab
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Living, Hartford Hospital
Hartford, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R-HHC-2017-0161
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.